Join Professor John Camm for his discussion on Atrial Fibrillation.
BBC Breakfast News
Patients and network staff talk about their experiences of being involved in clinical research.
Atrial Fibrillation Antiarrhythmic Drugs.
Professor John Camm discusses the two newest antiarrhythmic drugs dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away.
Watch us work.
Now's your chance to watch us work - check out the video below for a snapshot of our bustling team in action.